In the current study, we utilized the initial 24-hour blood tests to examine the SII, SIRI, PIV, and HALP indexes, as well as NLR and PLR levels, as potential biomarkers of inflammation in patients with ROP. The gene discussed is NAT10; the disease is retinopathy of prematurity.